138 related articles for article (PubMed ID: 7517773)
1. Up-regulation of neurotensin mRNA in the rat striatum after acute methamphetamine treatment.
Castel MN; Morino P; Dagerlind A; Hökfelt T
Eur J Neurosci; 1994 Apr; 6(4):646-56. PubMed ID: 7517773
[TBL] [Abstract][Full Text] [Related]
2. c-fos antisense oligonucleotide specifically attenuates haloperidol-induced increases in neurotensin/neuromedin N mRNA expression in rat dorsal striatum.
Merchant KM
Mol Cell Neurosci; 1994 Aug; 5(4):336-44. PubMed ID: 7804603
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of cocaine and methamphetamine on neurotensin/neuromedin N and preprotachykinin messenger RNA expression in unique regions of the striatum.
Adams DH; Hanson GR; Keefe KA
Neuroscience; 2001; 102(4):843-51. PubMed ID: 11182247
[TBL] [Abstract][Full Text] [Related]
4. Differential dopaminergic regulation of the neurotensin striatonigral and striatopallidal pathways in the rat.
Castel MN; Morino P; Nylander I; Terenius L; Hökfelt T
Eur J Pharmacol; 1994 Sep; 262(1-2):1-10. PubMed ID: 7813560
[TBL] [Abstract][Full Text] [Related]
5. Induction of neurotensin and c-fos mRNA in distinct subregions of rat neostriatum after acute methamphetamine: comparison with acute haloperidol effects.
Merchant KM; Hanson GR; Dorsa DM
J Pharmacol Exp Ther; 1994 May; 269(2):806-12. PubMed ID: 8182549
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the neurotensin striato-nigral pathway by D1 receptors.
Castel MN; Morino P; Hökfelt T
Neuroreport; 1993 Dec; 5(3):281-4. PubMed ID: 7507725
[TBL] [Abstract][Full Text] [Related]
7. Morphologically distinct subpopulations of neurotensin-immunoreactive striatal neurons observed in rat following dopamine depletions and D2 receptor blockade project to the globus pallidus.
Brog JS; Zahm DS
Neuroscience; 1996 Oct; 74(3):805-12. PubMed ID: 8884776
[TBL] [Abstract][Full Text] [Related]
8. Caffeine regulates neurotensin and cholecystokinin messenger RNA expression in the rat striatum.
Schiffmann SN; Vanderhaeghen JJ
Neuroscience; 1993 Jun; 54(3):681-9. PubMed ID: 8332255
[TBL] [Abstract][Full Text] [Related]
9. Blunting of the neurotensin mRNA response to haloperidol in the striatum of aging rats: possible relationship to decline in dopamine D2 receptor expression.
Dobie DJ; Merchant KM; Hamblin MW; Vatassery GT; Dysken MW; Dorsa DM
Brain Res; 1993 Jul; 616(1-2):105-13. PubMed ID: 8358601
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of haloperidol and clozapine on neurotensin gene transcription in rat neostriatum.
Merchant KM; Dobner PR; Dorsa DM
J Neurosci; 1992 Feb; 12(2):652-63. PubMed ID: 1531499
[TBL] [Abstract][Full Text] [Related]
11. Distinct and interactive effects of d-amphetamine and haloperidol on levels of neurotensin and its mRNA in subterritories in the dorsal and ventral striatum of the rat.
Zahm DS; Williams ES; Krause JE; Welch MA; Grosu DS
J Comp Neurol; 1998 Nov; 400(4):487-503. PubMed ID: 9786410
[TBL] [Abstract][Full Text] [Related]
12. Temporal changes in the messenger RNA levels of cellular immediate early genes and neurotransmitter/receptor genes in the rat neostriatum and substantia nigra after acute treatment with eticlopride, a dopamine D2 receptor antagonist.
Sirinathsinghji DJ; Schuligoi R; Heavens RP; Dixon A; Iversen SD; Hill RG
Neuroscience; 1994 Sep; 62(2):407-23. PubMed ID: 7830888
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical evidence for a neurotensin striatonigral pathway in the rat brain.
Castel MN; Morino P; Frey P; Terenius L; Hökfelt T
Neuroscience; 1993 Aug; 55(3):833-47. PubMed ID: 8105419
[TBL] [Abstract][Full Text] [Related]
14. Ciproxifan, a histamine H3-receptor antagonist/inverse agonist, modulates the effects of methamphetamine on neuropeptide mRNA expression in rat striatum.
Pillot C; Héron A; Schwartz JC; Arrang JM
Eur J Neurosci; 2003 Jan; 17(2):307-14. PubMed ID: 12542667
[TBL] [Abstract][Full Text] [Related]
15. Haloperidol rapidly increases the number of neurotensin mRNA-expressing neurons in neostriatum of the rat brain.
Merchant KM; Miller MA; Ashleigh EA; Dorsa DM
Brain Res; 1991 Feb; 540(1-2):311-4. PubMed ID: 2054626
[TBL] [Abstract][Full Text] [Related]
16. Central administration of the neurotensin receptor antagonist SR48692 attenuates vacuous chewing movements in a rodent model of tardive dyskinesia.
McCormick SE; Stoessl AJ
Neuroscience; 2003; 119(2):547-55. PubMed ID: 12770567
[TBL] [Abstract][Full Text] [Related]
17. Temporal dissociation of neurotensin/neuromedin N mRNA expression in topographically separate subsets of rat striatal neurons following administration of haloperidol.
Zahm DS; Williams ES; Poulad D; Krause JE
Brain Res Mol Brain Res; 1996 Nov; 42(1):71-8. PubMed ID: 8915582
[TBL] [Abstract][Full Text] [Related]
18. EEDQ reduces the striatal neurotensin mRNA response to haloperidol.
Adams MR; Dobie DJ; Merchant KM; Unis A; Dorsa DM
Peptides; 1997; 18(4):527-35. PubMed ID: 9210171
[TBL] [Abstract][Full Text] [Related]
19. Differential neurotensin responses to low and high doses of methamphetamine in the terminal regions of striatal efferents.
Frankel PS; Hoonakker AJ; Hanson GR; Bush L; Keefe KA; Alburges ME
Eur J Pharmacol; 2005 Oct; 522(1-3):47-54. PubMed ID: 16199030
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of mRNA levels encoding for the two isoforms of glutamate decarboxylase (GAD65 and GAD67) by dopamine receptors in the rat striatum.
Laprade N; Soghomonian JJ
Brain Res Mol Brain Res; 1995 Dec; 34(1):65-74. PubMed ID: 8750862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
